Article in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 12 citations in OpenAlex.
A Campbell SullivanGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio.
Gabrielle ZunigaGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio.ORCID 0000-0003-2118-1990
Paulino RamirezGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio.ORCID 0000-0001-8532-9590
Roman FernandezGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio.
Chen-Pin WangGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio.ORCID 0000-0002-1670-2838
Ji LiBarshop Institute for Longevity and Aging Studies, University of Texas Health San Antonio.
Lisa DavilaGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio.
Kristine PeltonBrown University Center for Alzheimer's Disease Research, Providence, RI.ORCID 0000-0002-9066-4366
Sandra GomezBarshop Institute for Longevity and Aging Studies, University of Texas Health San Antonio.
Claira SohnGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio.ORCID 0000-0002-1480-2421
Elias GonzalezGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio.
Marisa Lopez-CruzanBarshop Institute for Longevity and Aging Studies, University of Texas Health San Antonio.ORCID 0000-0003-0285-1012
David A GonzalezGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio.
Alicia ParkerGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio.
Eduardo ZilliGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio.ORCID 0000-0002-6743-8379
Gabriel A de ErausquinGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio.ORCID 0000-0001-6423-4461
Sudha SeshadriGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio.ORCID 0000-0001-6135-2622
Bess FrostGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio.ORCID 0000-0002-1212-8138
The University of Texas Health Science Center at San Antonio · USCedars-Sinai Medical Center · USBrown University · USRush University Medical Center · US
Funding
South Texas Alzheimer's Disease Research CenterP30AG066546 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Sudha Seshadri · 2021 to 2026
$24.0M
San Antonio OAIC - Research Education Component (REC)P30AG044271 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Adam Salmon, Elena Volpi · 2015 to 2026
$14.1M
TRAINING GRANT ON THE BIOLOGY OF AGINGT32AG021890 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Erzsebet Kokovay, JAMES FLOYD NELSON · 2003 to 2026
$11.4M
Investigating the role of transposable element dysregulation as a driver of neurotoxicity in tauopathyRF1NS112391 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI FROST, BESS · 2019 to 2019
$1.9M
Integrated Graduate Training Program in Neuroscience, UTHSCSAT32NS082145 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI David A Morilak · 2013 to 2026
$1.5M
South Texas Medical Scientist Training Program (STX-MSTP)T32GM113896 · NIGMS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CAVAZOS, JOSE E · 2018 to 2022
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A pilot study to investigate the safety and feasibility of antiretroviral therapy for Alzheimer's disease (ART-AD). · full record | OpenQuestion